Pacira BioSciences (NasdaqGS:PCRX) 2025 Conference Transcript

Pacira BioSciences (NasdaqGS:PCRX) 2025 Conference November 18, 2025 08:30 AM ET Company ParticipantsFrank Lee - CEOConference Call ParticipantsNone - AnalystFrank LeeIf you know a little bit about Pacira, you know a little bit about Pacira. You know that we're focused on musculoskeletal pain and adjacencies. We have three products: Exparel, our flagship product, which is a nerve block; Zilretta, a long-acting steroid for osteoarthritis; and Iovera, which is a medical device that uses cryoneurolysis to alle ...